22q11.2 Deletion Syndrome (DiGeorge): Heart Defects, Immunity, and Cognitive Effects

Imagine a newborn with a heart murmur detected on first physical examination. Cardiac imaging reveals tetralogy of Fallot—a serious congenital heart defect. The infant requires surgery. Additionally, the infant has recurrent infections—ear infections, respiratory infections. Immune testing reveals low T-cell counts. The baby has a cleft palate. Feeding difficulties. Later, developmental delay appears. Speech delay. Learning difficulties. The pattern of multiple, seemingly unrelated problems is eventually recognized as 22q11.2 deletion syndrome (DiGeorge syndrome). A single genetic deletion on chromosome 22 affects multiple organ systems—heart, immune system, palate, kidneys, parathyroids, ears, brain. Understanding that these are manifestations of a unified syndrome enables comprehensive, coordinated care. Cardiac surgery improves cardiac function. Immune evaluation guides infection prevention. Speech therapy helps communication. Early intervention supports development. Understanding the syndrome transforms a constellation of separate problems into a recognizable, manageable condition. 22q11.2 deletion syndrome is a genetic disorder caused by a deletion of approximately 3 million base pairs on chromosome 22. This deletion removes approximately 40 to 50 genes, resulting in multiple developmental abnormalities affecting the heart, immune system, palate, kidneys, parathyroids, ears, and brain. The condition is the most common 22q11 deletion disorder. The condition is autosomal dominant inheritance. Approximately 90 percent of cases are de novo mutations. Approximately 10 percent are inherited. 22q11.2 deletion syndrome affects approximately 1 in 2,000 to 1 in 3,000 live births. Approximately 15,000 to 20,000 Americans have the condition. What makes 22q11.2 deletion syndrome important is understanding the multi-system involvement. Cardiac defects are serious. Immune dysfunction increases infection risk. Cognitive effects impact development. Psychiatric complications emerge in adolescence and adulthood. Early diagnosis enables comprehensive, multidisciplinary management. Cardiac surgery improves cardiac function. Immune evaluation guides prophylaxis. Early intervention supports cognitive development. Mental health screening enables early psychological intervention. Understanding 22q11.2 deletion syndrome enables appropriate care and realistic expectations. In this comprehensive article, we will explore what 22q11.2 deletion syndrome is, understand the genetic deletion and consequences, recognize the multi-system manifestations, explore cardiac and immunologic complications, discover cognitive and psychiatric effects, and discover how comprehensive management improves outcomes.

Understanding 22q11.2 Deletion and Pathophysiology

Before we explore 22q11.2 deletion syndrome, we need to understand the genetic deletion and how it affects development. Chromosome 22. Location. Long arm (22q). Band 11. Sub-band 2. 22q11.2. Approximately 3 million base pairs. Approximately 40 to 50 genes. Genes affected. TBX1. T-box transcription factor. Critical. Cardiac development. Immune system. Palate. Ear development. Thymic development. COMT. Catechol-O-methyltransferase. Neurotransmitter. Dopamine. Norepinephrine. Metabolism. Cognitive function. Psychiatric symptoms. PRODH. Proline dehydrogenase. Enzyme. Proline metabolism. Developmental. Other genes. Approximately 35 to 45 additional genes. Various functions. Development. Organ formation. Protein synthesis. Cell signaling. 22q11.2 deletion types. Standard deletion. Approximately 3 million base pairs. Approximately 90 percent of cases. Includes TBX1. Smaller deletion. Approximately 1.5 million base pairs. Approximately 10 percent. Variable genes. Larger deletion. Rare. Approximately 3 to 5 million base pairs. Includes more genes. More severe. Nested deletion. Possible. Variable size. Variable genes. Breakpoints. Low copy repeats. LCR22. Similar sequences. Chromosome 22. Facilitate deletion. Recombination error. During meiosis. Results. Deletion. De novo deletion. Approximately 90 percent. New mutation. Neither parent affected. Germline deletion. Can pass. Offspring. 50 percent risk. Inherited deletion. Approximately 10 percent. From affected parent. 50 percent offspring. Genetic diagnosis. FISH. Fluorescence in situ hybridization. Chromosome analysis. Karyotype. May miss. Microarray. Array CGH. Chromosomal microarray. Gold standard. Detects. Deletion. Size. Breakpoints. DNA sequencing. Identifies. Specific genes. Copy number variation. Haploinsufficiency. One copy. Genes. Reduced expression. Insufficient. Protein levels. Insufficient. Development. Abnormality. TBX1 haploinsufficiency. Critical. Many manifestations. Cardiac. Immune. Palate. Ears. TBX1. Early development. Neural crest. Pharyngeal development. Critical. TBX1 required. Normal development. Neural crest cells. Cardiac neural crest. Conotruncal development. Truncus arteriosus. Separated. Aorta. Pulmonary artery. TBX1 mutation or haploinsufficiency. Defective separation. Conotruncal defects. Second heart field development. TBX1. Critical. Aortic arch. Abnormalities. 22q11.2 deletion. Cardiac defects. Diverse. TBX1 haploinsufficiency. Primary. Other genes. Possible contributions. Thymic development. TBX1. Important. Thymus. Formation. Development. 22q11.2 deletion. Thymic hypoplasia. Aplasia. Decreased T cells. Immunodeficiency. Variable. Severity. Partial thymic hypoplasia. Near-normal T cells. Or mild reduction. Complete thymic aplasia. No T cells. Severe immunodeficiency. Rare. Immune dysfunction. Most common. Variable severity. Palatal development. TBX1. Neural crest contribution. Palate. 22q11.2 deletion. Cleft palate. Secondary cleft. Primary cleft. Rare. Velopharyngeal insufficiency. VPI. Soft palate. Incomplete closure. Speech. Hypernasality. Requires treatment. Parathyroid development. 22q11.2. Approximately 17 to 34 percent. Hypocalcemia. Hypoparathyroidism. Parathyroid gland. Hypoplasia. Reduced function. Calcium regulation. PTH. Reduced. Calcium. Low. Phosphate. High. Seizure risk. From hypocalcemia. Requires monitoring. Treatment. Calcium supplementation. Vitamin D. PTH. Renal development. Approximately 30 percent. Renal anomalies. Kidney development. Hypoplasia. Small kidney. Dysplasia. Abnormal development. Agenesis. Kidney absent. Single kidney. Function. Usually adequate. Monitoring. Renal function. Important. Ear development. External ear. Abnormalities. Low-set. Malformed. Hearing loss. Conductive. Ossicular abnormalities. Stapes. Fixation. Sensorineural. Cochlear. Nerve. Variable. CNS development. Brain development. Structural abnormalities. Possible. Corpus callosum. Abnormality. Polymicrogyria. Brain surface. White matter. Abnormalities. Intelligence. Variable. Intellectual disability. 30 to 40 percent. Mild to moderate. Normal intelligence. 60 to 70 percent. Learning disability. Common. 50 to 70 percent. Speech and language delay. ADHD. Attention deficit hyperactivity. Common. Psychiatric. Schizophrenia. Increased risk. 20 to 25 percent. Higher than general population. 1 percent. Bipolar disorder. Increased risk. Anxiety. Depression. Other psychiatric. Increased risk. COMT gene. Dopamine metabolism. Affects. Dopamine levels. Brain function. Psychiatric risk. Related. Cognitive function. Variable. Intelligence quotient (IQ). Average. Some. Average to high. Others. Intellectual disability. Learning disability. Even average IQ. Specific areas. Reading. Math. Executive function. Difficulties. Require support. The pathophysiology explains the multi-system manifestations of 22q11.2 deletion syndrome.

What is 22q11.2 Deletion Syndrome?

22q11.2 deletion syndrome is a genetic disorder caused by a microdeletion on chromosome 22 resulting in a constellation of birth defects affecting the heart, immune system, palate, parathyroids, kidneys, ears, and brain. Alternative names. DiGeorge syndrome. Velocardiofacial syndrome. VCFS. Conotruncal anomaly face syndrome. CAFS. Shprintzen syndrome. Different terminology. Same condition. 22q11.2 deletion syndrome. Current. Most specific. Cardiac manifestations. Conotruncal defects. Tetralogy of Fallot. Most common. Approximately 25 percent. Transposition of great arteries. Approximately 15 percent. Truncus arteriosus. Approximately 10 percent. Interrupted aortic arch. Approximately 10 percent. Aortic arch anomalies. Hypoplastic left heart. Right-sided aortic arch. Ventricular septal defect (VSD). Atrial septal defect (ASD). Right-sided aortic arch. Approximately 35 percent. Other anomalies. Mitral valve prolapse. Aortic regurgitation. Variable. Cardiac severity. Some lethal. Neonatal. Prostaglandin E1. Emergency. Surgery. Others. Compatible life. Monitoring required. Some minor. Asymptomatic. Discovered incidentally. Approximately 75 percent. Have cardiac defect. Approximately 25 percent. No cardiac defect. Immune manifestations. Thymic hypoplasia. Common. Approximately 70 to 80 percent. Partial. Complete aplasia. Rare. T cell deficiency. Variable. Absolute lymphocyte count. Usually mild. Approximately 70 percent. Normal or near-normal. Approximately 30 percent. T cell deficiency. Mild to moderate. Approximately less than 1 percent. Severe combined immunodeficiency. SCID. Severity. Variable. Infection risk. Increased. Recurrent. Ear. Respiratory. Gastrointestinal. Sinusitis. Pneumonia. Serious. Possible. Immunizations. Response. Variable. Live vaccines. Caution. T cell deficiency. Severe. Live vaccines. Contraindicated. Hypocalcemia. Parathyroid hypoplasia. Approximately 17 to 34 percent. Hypocalcemia. Approximately 60 percent. Hypoparathyroidism. Asymptomatic. Some. Symptomatic. Seizures. From hypocalcemia. Paresthesias. Muscle cramps. Tetany. Muscle contractions. Requires treatment. Calcium supplementation. Vitamin D. PTH. Cleft palate. Approximately 30 percent. Cleft palate. Primary. Rare. Secondary. Most common. Velopharyngeal insufficiency. VPI. Approximately 20 percent. Soft palate. Incomplete closure. Speech hypernasal. Nasality. Intelligibility. Affected. Feeding. Sometimes difficult. Palatal repair. Usually 12 to 18 months. Speech therapy. Post-repair. Renal abnormalities. Approximately 30 percent. Kidney anomalies. Hypoplasia. Dysplasia. Agenesis. Unilateral. Bilateral rare. Function. Usually adequate. Monitoring. Renal function. Important. Genitourinary. Hypospadia. Cryptorchidism. Females. Reproductive. Usually normal. Hearing loss. Approximately 30 percent. Conductive hearing loss. Ossicular abnormalities. Sensorineural. Cochlear. Variable. Bilateral. Unilateral. Audiometry. Assessment. Hearing aids. If indicated. Speech development. Affected. By hearing loss. Developmental delay. Speech delay. Common. Intellectual disability. Approximately 30 to 40 percent. Mild to moderate. Learning disability. Approximately 50 to 70 percent. Specific learning disabilities. Reading. Math. Executive function. Behavioral. ADHD. Common. Impulse control. Attention. Aggression. Anxiety. Behavioral problems. Psychiatric. Schizophrenia. Approximately 20 to 25 percent. Lifetime risk. Compared. 1 percent. General population. Prodromal symptoms. Adolescence. Young adulthood. Delusions. Hallucinations. Disorganized. Bipolar disorder. Anxiety disorders. Depression. Increased risk. Other complications. Growth. Short stature. Approximately 40 percent. Growth hormone. Possible. Assessment. Renal complications. Chronic kidney disease. Rare. Monitoring. Renal function. Cardiac complications. Arrhythmias. Sudden cardiac death. Risk increased. Ventricular arrhythmia. Screening. ECG. Holter monitor. If symptoms. Palatal/speech complications. Velopharyngeal insufficiency. Speech therapy. Sometimes inadequate. Surgical intervention. Pharyngeal flap. Sphincter pharyngoplasty. Speech improvement. Orthognathic surgery. Jaw abnormalities. Sometimes. Correction. Orthodontics. Skeletal features. Micrognathia. Small jaw. Retrognathia. Posterior jaw. Dental. Crowding. Malocclusion. Orthodontics. Often needed. The multi-system nature requires comprehensive management.

Recognizing 22q11.2 Deletion Syndrome: Neonatal to Childhood Presentations

22q11.2 deletion syndrome has variable presentations recognizable from neonatal period through adulthood. Neonatal presentation (0 to 28 days). Cardiac defect. Obvious. Cyanosis. Blue baby. Tetralogy of Fallot. Heart murmur. Cardiac imaging. Confirms. Prostaglandin E1. Patent ductus arteriosus. Patent. Emergency cardiac surgery. Sometimes. NICU. Admission. Intensive care. Cleft palate. Visible. Feeding difficulties. Speech. Later. Hypocalcemia. Seizures. Newborn. Irritability. Tremors. Seizure. Blood calcium. Assessment. Treatment. Calcium supplementation. Vitamin D. Infection. Recurrent. Ear infection. Respiratory infection. Suggests. Immune evaluation. T cell count. Assessment. Multiple birth defects. Recognition. Pattern recognition. Genetics. Genetics consultation. 22q11.2 deletion. Suspected. Microarray. Testing. Confirms. Comprehensive approach. Enables. Infancy (1 to 12 months). Cardiac defect. Post-operative. Recovery. If surgery. Imaging. Follow-up. Echocardiography. Assessment. Function. Arrhythmias. Monitoring. Growth. Post-operative. Feeding. Sometimes. Difficult. GI. Reflux. Common. Growth monitoring. Height. Weight. Developmental assessment. Motor. Gross. Fine. Speech. Language. Cognitive. Social-emotional. Early intervention. Physical therapy. Occupational therapy. Speech therapy. Developmental support. Immune surveillance. T cell count. Baseline. Periodic. Infection. Frequency. Pattern. Prophylaxis. If indicated. Pneumocystis jirovecii pneumonia (PJP). Trimethoprim-sulfamethoxazole. Prevention. If T cell deficiency. Significant. Infections. Management. Antibiotics. Appropriate. Immunizations. Response. Assessment. Antibodies. If needed. Repeat. Post-response assessment. Calcium monitoring. Serum calcium. Periodic. PTH. Assessment. Hypocalcemia. Continuing. Supplementation. Ongoing. Hearing. Assessment. Newborn hearing screen. Confirmation. If abnormal. Audiometry. Comprehensive. Degree. Type. Hearing aids. If indicated. Early. Speech development. Hearing loss. Hearing aids. Critical. Toddlerhood (1 to 3 years). Speech and language. Delay. Common. Speech therapy. Intensive. Early intervention. Continued. Multiple modalities. Spoken. Sign language. AAC. Devices. Visual supports. Gross motor. Development. Walking. Delayed sometimes. Physical therapy. Continued. Fine motor. Occupational therapy. Continued. Self-care. ADL. Skills. Cognitive. Developmental assessment. IQ. Developmental quotient. Early. Baseline. Periodic. Track progress. Learning disabilities. Identification. Special education services. Consideration. Behavioral. Behavior problems. Emerging. ADHD. Possible. Difficult temperament. Emotional dysregulation. Parenting support. Behavioral strategies. Counseling. Cleft palate. Repair. Planning. Usually. 12 to 18 months. Feeding. Post-repair. Usually. Better. Speech therapy. Post-repair. Post-operative. Hearing. Continued monitoring. Audiometry. Periodic. Infection. Continued. Frequency. Pattern. Growth. Monitoring. Calcium. Continued monitoring. Supplementation. If still needed. Psychological. Family adjustment. Multiple diagnoses. Overwhelming. Support. Counseling. Support groups. Early childhood (3 to 6 years). School readiness. Pre-K or kindergarten. Accommodations. Important. Speech and language. Continued. Speech therapy. Beneficial. AAC. Devices. If indicated. Academics. Reading readiness. Letter recognition. Numbers. Variable. Early readers. Some. Others. Later. Depends. Intelligence. Learning disability. Severity. Behavioral. ADHD. Continued. Attention. Impulse control. Classroom. Behavioral strategies. Positive reinforcement. Clear expectations. Teacher education. CHARGE syndrome. What to expect. Accommodations. Possible. Peer relationships. Developing. Friendship important. Body image. Beginning. Awareness. Differences. Facial features. Palatal scar. Hearing aids. Speech. Differences. Self-consciousness. Developing. Emotional adjustment. Support. Important. Psychological. Anxiety. Possible. Excessive worrying. Reassurance. Important. Growth. Monitoring. Short stature. Possible. Growth hormone. Assessment. If indicated. Infection. Continuing. Monitoring. Frequency. Pattern. Immune function. Periodic assessment. Calcium. Continued monitoring. School-age (6 to 12 years). Academic learning. Intelligence. Variable. Average. Mainstream education. With support. Some support. Intellectual disability. Special education. Modified curriculum. Smaller class. Individualized teaching. Mixed. Inclusion. With support. Learning disabilities. Specific. Reading. Math. Executive function. Accommodations. Necessary. School support. Important. Speech and language. Continued. Speech therapy. Beneficial. Some. Clear speech. Others. Difficult. AAC. Devices. Continue. Peer relationships. Important. Bullying. Risk. Advocacy. Important. Communication. Understanding. CHARGE syndrome. Staff. Peer education. Emotional. ADHD. Continued. Medication. Behavioral. Combined. Anxiety. Possible. Worried. Reassurance. Coping strategies. Behavioral. Counseling. If indicated. Cardiac. Monitoring. Imaging. Periodic. Echocardiography. If indicated. Arrhythmia. Screening. ECG. Holter monitor. If symptoms. Hearing. Monitoring. Audiometry. Periodic. Devices. Functioning. Maintenance. Addressing. Adolescence (12 to 18 years). Psychiatric emergence. Schizophrenia risk. Increases. Adolescence. Young adulthood. Prodromal symptoms. Social withdrawal. Paranoia. Odd thinking. Hallucinations. Screening. Important. Mental health assessment. Periodic. Professional. Evaluation. If concerns. Bipolar disorder. Anxiety. Depression. Increased risk. Assessment. Treatment. If indicated. Identity. Self-image. Body image. Differences. Acceptance. Important. Peer relationships. Dating. Social. Acceptance. Important. Psychiatric support. Counseling. If difficulties. Sexual development. Puberty. Normal timing. Usually. Sexual education. Important. Reproductive. Future. Genetic. Genetic counseling. Offspring. 50 percent. Discussed. Education. College. Possible. Accommodations. Accessibility. Support services. Important. Career planning. Realistic assessment. Abilities. Intellectual disability. Severity. Vocational assessment. Employment. Possible. Variable. Depends. Intelligence. Learning disability. Support. Work disability. Possible. Type III. Intellectual disability. Significant. Supported employment. Adulthood (18+ years). Psychiatric. Schizophrenia. Emerging. Adolescence. Young adulthood. Ongoing. Management. Antipsychotic medication. Therapy. Support. Bipolar disorder. Anxiety. Depression. Management. Medication. Therapy. Support. Cardiac. Arrhythmias. Monitoring. ECG. Holter monitor. Palpitations. Syncope. Evaluation. Arrhythmia. Treatment. If needed. Growth. Height. Usually. Near-adult. Short stature. If present. Ongoing. Hearing. Variable. Hearing aids. Continued. Cochlear implant. Possible. If profound. Dental. Progressive. Malocclusion. Orthodontics. Completed. Retained. Dental care. Ongoing. Relationships. Marriage. Family. Possible. Parenting. Ability. Depends on. Intellectual disability. Support. Possible. Genetic counseling. Offspring. 50 percent risk. Employment. Variable. Intellectual disability. Type. Severity. Supported employment. Possible. Quality of life. Good. With support. The diverse presentations require lifelong, comprehensive, multidisciplinary care.

Diagnosis: Recognizing 22q11.2 Deletion Syndrome—Clinical and Genetic Approaches

Diagnosing 22q11.2 deletion syndrome requires clinical suspicion and genetic confirmation. Clinical features suggesting syndrome. Cardiac defect. Conotruncal. Tetralogy. Transposition. Truncus. Interrupted aortic arch. Dysmorphic features. Micrognathia. Retrognathia. Hypertelorism. Short philtrum. Ear abnormalities. Cleft palate. Hearing loss. Growth restriction. Developmental delay. Immune dysfunction. Infections. T cell deficiency. Hypocalcemia. Seizures. Intelligence variable. Learning disability. ADHD. Behavioral problems. Psychiatric symptoms. Schizophrenia. Bipolar disorder. Family history. Family member. 22q11.2 deletion. DiGeorge syndrome. Known. Genetic predisposition. Genetic counseling. Testing. Before after. Important. Clinical assessment. History. Pregnancy. Maternal diabetes. Infection. Fetal alcohol. Medications. Radiation. Delivery. Complications. Growth. Birth weight. Head circumference. Dysmorphic features. Facial features. Ears. Palate. Cardiac. Physical examination. Heart murmur. Cyanosis. Respiratory distress. Other findings. Immune assessment. Infection history. Frequency. Type. Severity. Dental. Speech. Learning. Developmental. Assessment. Developmental screening. Cognitive testing. IQ. Developmental quotient. Early. Psychiatric. Screening. For adolescent. Adult. Mental health history. Paranoia. Hallucinations. Delusions. Mood. Anxiety. Depression. Family history. Psychiatric. Genetic testing. DNA microarray. Chromosomal microarray array (CMA). Gold standard. Detects. 22q11.2 deletion. Size. Breakpoints. Sensitivity. Approximately 99 percent. 22q11.2 deletion. Microarray. Superior. Karyotype. Karyotype. Routine. May miss. Microdeletion. FISH. Fluorescence in situ hybridization. Specific probe. 22q11. Region. Confirms. Deletion. Targeted. If microarray. Not available. PCR. Polymerase chain reaction. Specific genes. Quantifies. Copy number. Detects. Deletion. Genetic testing result interpretation. Pathogenic deletion. Clearly cause 22q11.2 deletion syndrome. Confirms diagnosis. Genetic counseling. Inheritance. 50 percent if heterozygous parent. De novo. If neither parent. Benign variant. No disease. Variant of uncertain significance (VUS). Unknown. Effect. Requires research. Genetic counseling. Inheritance discussion. Family planning. Prenatal diagnosis options. Genetic counselor important. Cardiac imaging. Echocardiography. Gold standard. Heart structure. Defects. Quantifies. Function. Ejection fraction. Baseline. Periodic. Cardiac CT or MRI. Complex anatomy. Surgical planning. Chest X-ray. Screening. Heart size. Lung fields. Aortic arch. Imaging. Right-sided aortic arch. Approximately 35 percent. CT. Confirms. Surgical planning. ECG. Electrocardiogram. Baseline. Arrhythmia screening. Holter monitor. Continuous monitoring. If indicated. Immune evaluation. Complete blood count (CBC). White cell count. Lymphocyte count. T cell count. CD3+ T cells. CD4+ T cells. CD8+ T cells. Baseline. Periodic. If T cell deficiency. Severe. PJP prophylaxis. Trimethoprim-sulfamethoxazole. Immunoglobulin levels. IgG. IgA. IgM. Baseline. Assessment. Function. Vaccine response. Tetanus. Diphtheria. Others. Titers. Post-vaccination. Assess response. Calcium and parathyroid assessment. Serum calcium. Baseline. Periodic. If hypocalcemia. Treatment. PTH. Parathyroid hormone. Assessment. Parathyroid function. 24-hour urine calcium. If hypercalcemia. Parathyroid imaging. Ultrasound. If parathyroid abnormality. Renal imaging. Ultrasound kidneys. Baseline. Assess. Kidney. Size. Function. Hydronephrosis. Renal function. Serum creatinine. eGFR. Baseline. Periodic. Hearing assessment. Newborn hearing screening. Confirmatory. Audiometry. Degree. Type. If indicated. Imaging. Temporal bone. CT. Pre-cochlear implant assessment. Auditory brainstem response (ABR). Objective. Age-specific. Developmental assessment. Developmental psychology. Intelligence testing. IQ test. Developmental quotient. Early. Baseline. Periodic. Track progress. Identifies. Learning disability. Special education services. Recommendations. Speech and language assessment. Speech pathologist. Speech intelligibility. Language comprehension. Expressive. Receptive. Language disorder assessment. Intervention recommendations. Psychiatric assessment. Adolescent and adult. Mental health history. Structured interview. Screening. Schizophrenia. Bipolar disorder. Anxiety. Depression. Substance abuse. Suicide risk. Professional psychiatric evaluation. If concerns. The diagnosis requires comprehensive clinical and genetic evaluation.

Management: Comprehensive Multidisciplinary Care

22q11.2 deletion syndrome management requires comprehensive, coordinated care across multiple specialties. Cardiac management. Congenital heart defect. Cardiologist. Evaluation. Echo. Assessment. Severity. Management plan. Prostaglandin E1. Patent ductus arteriosus. Patent. If needed. Surgery. Timing. Depends. Defect. Severity. Often neonatal. Post-operative follow-up. Imaging. Echocardiography. Periodic. Arrhythmia assessment. ECG. Monitoring. Medication. If indicated. ICD (implantable cardioverter-defibrillator). If arrhythmia risk. Activity recommendations. Depends. Cardiac status. Restrictions. If significant. Immune management. T cell assessment. Complete blood count. T cell count. Baseline. Periodic. PJP prophylaxis. Trimethoprim-sulfamethoxazole (TMP-SMX). If T cell count. Less than 200. Lymphocytes. Continued. Until normal. Immunoglobulin. Levels. Assessment. Replacement. If deficient. Intravenous immunoglobulin (IVIG). If indicated. Severe deficiency. Immunizations. Response assessment. Antibodies. Titers. Post-vaccination. Repeat. If inadequate. Live vaccines. Caution. Contraindicated. Severe T cell deficiency. Infection management. Antibiotics. Appropriate. Fever workup. If fever. Prophylaxis. If recurrent infections. Long-term. Antibiotic. Or change. Immunoglobulin replacement. If indicated. Palatal management. Cleft palate repair. Plastic surgeon. Timing. Usually 12 to 18 months. Speech development. Important. Prior. Feeding. Nasogastric tube. Temporary. Post-repair. Oral feeding. Usually. Speech and language. Speech pathologist. Assessment. Early. Therapy. Intensive. Cleft palate. Developmental delay. Speech pathology. Multiple modalities. Spoken language. Sign language. AAC devices. Visual supports. Feeding support. Nasogastric tube. Temporary. If necessary. Feeding therapy. Techniques. Swallowing. Difficulty. Persistent. Gastroenterology. Referral. Reflux. Medication. Proton pump inhibitor. H2 blocker. Managing. Nutritional. Needs. Increased. Caloric needs. High-calorie formula. Fortification. Tube feeding. If needed. Calcium and parathyroid management. Serum calcium. Monitoring. Baseline. Periodic. Hypocalcemia. Calcium supplementation. Calcium carbonate. Calcium citrate. Vitamin D. Active form (calcitriol). Or inactive (cholecalciferol). PTH. Monitoring. If persistent. Low-normal. PTH. Normal. Ongoing therapy. Hypoparathyroidism. Lifelong. Usually. Treatment. Continuation. Seizure precautions. If hypocalcemia. Seizure risk. Antiepileptic medication. If indicated. Monitoring. Calcium levels. Adjustments. Therapy. As needed. Renal management. Imaging. Ultrasound. Baseline. Assessment. Kidney. Renal function. Serum creatinine. eGFR. Baseline. Periodic. Monitoring. Adequate hydration. Important. Avoid nephrotoxic. Medications. If possible. Nephrology. Referral. If renal dysfunction. Hearing management. Newborn hearing screen. Confirmatory. Audiometry. Degree. Type. Conductive. Sensorineural. Mixed. Amplification. Hearing aids. Early. Cochlear implant. Consideration. If profound. Bilateral. Inadequate. Response. Hearing aids. Education. Audiologist. Batteries. Maintenance. Function. Critical. Speech development. Dependent. Speech therapy. Early. Intensive. Multiple modalities. Sign language. AAC devices. Visual supports. Pediatric otolaryngology. If ear infection. Recurrent. Myringotomy. Tubes. Insertion. Drainage. Reduces. Infection. Developmental support. Early intervention. Critical. Physical therapy. Gross motor. Speech therapy. Language development. Occupational therapy. Self-care. Fine motor. ADL skills. Special education. IEP or 504 plan. If indicated. Cognitive assessment. IQ testing. Developmental quotient. Early. Baseline. Periodic. Identifies. Intellectual disability. Learning disability. Severity. Guide. Support. Services. Genetic counseling. Family. Inheritance. Autosomal dominant. 50 percent offspring. If parent. De novo. If neither parent. 90 percent of cases. Family testing. Relatives. At-risk. Determination. Carrier status. Enable. Anticipatory care. Early intervention. If indicated. Psychological support. Family. Adjustment. Multiple diagnoses. Challenging. Counseling. Support groups. 22q11 organizations. Support. Coping. Information. Resources. Behavioral and psychiatric. ADHD. Management. Stimulants. Non-stimulants. Behavioral. Combined. Anxiety. Depression. SSRIs. Other antidepressants. Psychotherapy. Counseling. Behavioral. Support. Schizophrenia. Antipsychotic medication. Therapy. Support. Bipolar disorder. Mood stabilizer. Antipsychotic. Therapy. Support. Mental health monitoring. Adolescent and adult. Periodic screening. Professional evaluation. If concerns. Educational support. School. Accommodations. IEP or 504 plan. Teacher education. 22q11 deletion syndrome. What to expect. Peer education. Reducing bullying. Social skills training. Peer relationships. Special education. If needed. Vocational training. Adolescent and adult. Vocational assessment. Job skills. Career planning. Supported employment. If indicated. The comprehensive approach prevents complications and enables optimal outcomes.

Frequently Asked Questions (FAQs)

Q1: Is 22q11.2 deletion syndrome fatal?

Not necessarily. Variable severity. Cardiac defect. Life-threatening. Newborn. Prostaglandin E1. Surgery. Survival. Possible. Modern cardiac care. Most survive. Infancy. Complications. Late childhood. Others. Near-normal lifespan. Many. Adulthood. Quality of life. Good. With management.

Q2: Will my child with 22q11.2 deletion syndrome have intellectual disability?

Variable. Approximately 30 to 40 percent. Intellectual disability. Mild to moderate. Approximately 60 to 70 percent. Average intelligence. Learning disability. Approximately 50 to 70 percent. Even average intelligence. Specific areas. Reading. Math. Executive function. Difficulties. Require support. Early intervention. Physical therapy. Speech therapy. Occupational therapy. Special education. Maximizes development. Academic achievement. Variable. Depends on severity.

Q3: What is the psychiatric risk with 22q11.2 deletion syndrome?

Schizophrenia. Approximately 20 to 25 percent lifetime. Compared. 1 percent general population. 20 to 25-fold increased. Bipolar disorder. Increased. Anxiety disorders. Depression. Increased. Psychiatric screening. Adolescent and adult. Important. Prodromal symptoms. Social withdrawal. Paranoia. Odd thinking. Early detection. Treatment. Improves outcomes. Mental health support. Essential.

Q4: How is 22q11.2 deletion syndrome diagnosed?

Microarray. Chromosomal microarray array. Gold standard. Detects deletion. Size. Breakpoints. FISH. Specific probe. Confirms. Genetic counseling. Important. Inheritance discussion. Genetic testing. Family members. At-risk. Determination. Carrier status. Genetic testing. Confirms. Diagnosis. Enables comprehensive care.

Q5: Can people with 22q11.2 deletion syndrome have normal relationships and families?

Yes. Intelligence variable. Some average. Relationships. Marriage. Family. Possible. Parenting ability. Depends on intellectual disability severity. Support. Possible. Genetic counseling. Important. Offspring risk. 50 percent if carrier. Genetic testing. Partner. Discussion. Family planning. Options. Prenatal diagnosis. Possible. Normal relationships and families achievable.

Key Takeaways

22q11.2 deletion syndrome is genetic disorder. Chromosome 22. Microdeletion. Approximately 3 million base pairs. Approximately 40 to 50 genes. Autosomal dominant. 50 percent offspring risk. Approximately 1 in 2,000 to 3,000 live births. Approximately 15,000 to 20,000 Americans. Approximately 90 percent de novo. Approximately 10 percent inherited. Cardiac defects. Approximately 75 percent. Tetralogy of Fallot. Transposition. Truncus arteriosus. Interrupted aortic arch. Variable. Life-threatening. Neonatal. Or compatible life. Surgery. Often necessary. Immune dysfunction. Approximately 70 to 80 percent. Thymic hypoplasia. T cell deficiency. Approximately 70 percent mild. Approximately 30 percent moderate. Infection risk increased. Prophylaxis sometimes. Hypocalcemia. Approximately 17 to 34 percent. Parathyroid hypoplasia. Hypoparathyroidism. Seizure risk. Treatment. Calcium supplementation. Vitamin D. PTH. Cleft palate. Approximately 30 percent. Secondary primary rare. Velopharyngeal insufficiency. Approximately 20 percent. Speech. Feeding. Impact. Repair usually 12 to 18 months. Hearing loss. Approximately 30 percent. Conductive. Sensorineural. Mixed. Hearing aids or cochlear implants. Renal anomalies. Approximately 30 percent. Variable. Usually functional. Monitoring. Developmental delay. Intellectual disability. Approximately 30 to 40 percent. Learning disability. Approximately 50 to 70 percent. Early intervention maximizes development. Psychiatric. Schizophrenia. Approximately 20 to 25 percent lifetime. Increased 20 to 25-fold. Bipolar disorder. Anxiety. Depression. Increased. Screening adolescent and adult. Important. Management. Cardiac surgery if needed. Follow-up. Immune surveillance. Infection prevention. Calcium monitoring. Hypocalcemia treatment. Palatal repair. Speech therapy. Hearing aids or cochlear implants. Developmental support. Physical therapy. Speech therapy. Occupational therapy. Special education. Psychological support. Family counseling. Mental health screening and treatment. Psychiatric. Genetic counseling. Family planning. Prenatal diagnosis. Outcomes. Variable. Severity dependent. Cardiac. Most survive infancy. Quality of life. Good with comprehensive management. Intelligence variable. Early intervention. Maximizes development. Psychiatric screening. Early treatment. Important. 22q11.2 deletion syndrome—serious genetic condition—treatable. Modern care—comprehensive—enables meaningful outcomes.

References

1. World Health Organization (WHO). “22q11.2 Deletion Syndrome: Classification and Management.” Retrieved from https://www.who.int/
2. 22q11 International Network. “22q11 Information and Resources.” Retrieved from https://www.22q11.com/
3. Mayo Clinic. “22q11.2 Deletion Syndrome.” Retrieved from https://www.mayoclinic.org/
4. Cleveland Clinic. “DiGeorge Syndrome (22q11.2 Deletion).” Retrieved from https://my.clevelandclinic.org/
5. National Institutes of Health. “22q11.2 Deletion Syndrome.” Retrieved from https://www.nih.gov/
6. American Academy of Pediatrics. “22q11.2 Deletion Syndrome Management.” Retrieved from https://www.aap.org/

Related Articles on ObserverVoice.com

Explore more health and science topics on our platform:

• Genetic Disorders: Understanding Chromosomal Deletions
• Congenital Heart Defects: Understanding Cardiac Birth Abnormalities
• Immune Deficiency: Understanding T Cell Function and Immunity
• Thymic Hypoplasia: Understanding Immune System Development
• Schizophrenia: Understanding Psychotic Disorders in Genetic Syndromes
• Developmental Delay: Understanding Early Intervention and Support
• Living With Complex Genetic Syndromes: Multidisciplinary Care Coordination

Disclaimer

This article provides educational information adapted from publicly available health sources including WHO materials. This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. [ObserverVoice.com] is a news and information platform—not a healthcare provider. If your child has congenital heart defects, immune dysfunction, cleft palate, or developmental delay, consult qualified cardiologists, immunologists, geneticists, or genetic counselors for comprehensive evaluation and genetic testing. Early diagnosis enables early intervention. Comprehensive, coordinated multidisciplinary care dramatically improves outcomes. Multiple specialists required—cardiologist, immunologist, ENT, speech pathologist, developmental specialist, psychologist, psychiatrist, geneticist. Early intervention programs critical. Physical therapy, speech therapy, occupational therapy, special education. Family support essential. Genetic counseling important for family planning and inheritance discussion. With appropriate comprehensive management, children with 22q11.2 deletion syndrome achieve meaningful lives with good quality of life. Always seek guidance from licensed healthcare specialists for diagnosis and personalized medical management.

Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.

Follow Us on Twitter, Instagram, Facebook, & LinkedIn